Home · TRON Translational Oncology Mainz

nav.hidden, nav ul [x-cloak], nav ul li ul { display: block !important; } This website requires Javascript for some parts to function properly. Your experience may vary.

June 2nd, 2025

curATalk seminar series

We are looking forward to the next curATalk, which will be hosted by the curATime PI Prof. Wolfram Ruf of the University Medical Center Mainz. Our guest speaker Dr. Craig Morrell from the Cardiovascular Research Institute at the University of Rochester, USA, will talk about “Platelets and Megakaryocytes at the Immune Interface.”

May 13th, 2025

Visit by Prof. Renata Stripecke from University Hospital Cologne

On May 15th, Prof. Renata Stripecke from the Institute of Translational Immune-Oncology at the Cancer Research Center Cologne Essen will visit us.

curatalks-carolin-&-marc-lerchenmuller-einladung.png

May 12th, 2025

curATalk seminar series

We are looking forward to our next on-site curATalks on May 15th with Carolin Lerchenmüller, Professor of Gender Medicine, and Marc Lerchenmüller, Assistant Professor of Technological Innovation and Management.

May 6th, 2025

TRON Insights at the upcoming CIMT Annual Meeting 2025

TRON scientist ‌Ayline Kübler has been chosen for a short talk at the upcoming 22nd CIMT Annual Meeting starting on May 12th, 2025. Her talk will address the use of cationic RNA-lipoplexes (LPX) to target tumor tissue in lung for delivery of mRNA-encoded cytokines.

May 2nd, 2025

New cooperation funded by the National Strategy for Gene and Cell-based Therapies.

We have initiated a new cooperation project with the University Medical Center Mainz within the Translational Tandem Program (nTTP-GCT) together with Prof. Daniel Dürr.

April 3rd, 2025

Seminars in Translational Science

As our next SITO speaker we kindly invited Dr. Altuna Akalin from the Berlin Institute for Medical Systems Biology (BIMSB) at the Max Delbrück Center for Molecular Medicine in Berlin. He will give an overview about “How AI will reshape life sciences research: Examples from drug development and healthcare”.

We are TRON

TRON is an independent non-profit translational research organization. We pursue new diagnostics and drugs for the treatment of diseases with high medical need. We apply our transdisciplinary competencies in genomics and immunology to develop novel platforms for the identification and validation of ‘omics’-based biomarkers, to modulate immune system components for use in personalized therapies. Collaborating with academia and industry, TRON executes research at the leading edge to support innovative drug design for human health.

Our new research building

Our new research building is currently under construction on the grounds of Mainz University Medical Center according to a concept by Nickl und Partner architects. This envisions a modern, light-flooded building with laboratory and office areas as well as communication zones with up to 10,800 m² of usable space, which will be integrated into the adjacent green areas and the listed Fichte settlement. As a result of intensive coordination with the city of Mainz and all parties involved, construction preparations have been initiated in record time.

Our Research Focus

TRON conducts collaborative research on disease genomics and therapeutic modulation of the immune system. Specializing in cancer immunology and genomics, our research teams develop tailored bioinformatic and novel biostatistical approaches to identify and characterize disease-relevant molecular targets. We design and improve cutting edge technologies for biomarker discovery and biopharmaceutical development, including platforms for immune-based therapies such as RNA vaccines and cellular therapies.